AI in Pharma Adoption, Part 2: “Good AI Begins With Good Data”
By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team Having data of quality is the first step in the Artificial Intelligence (AI)/ Machine Learning (ML) journey to get reliable models and valuable AI/ML outputs. There are many issues regarding data quality that can affect the design of the … Read more
